Periodontal Microbiology & Pathogenesis MCQ

Periodontal disease is a microbially initiated, host-mediated destruction of the periodontium. A dental biofilm forms at the gingival margin, the microbial community shifts toward anaerobic Gram-negative pathogens (dysbiosis), and the host's own inflammatory response resorbs the attachment apparatus in trying to control the infection. Most of the attachment loss is not direct bacterial damage; it is the body's cytokines, matrix metalloproteinases, and bone-resorbing signals (RANKL) at work. Gingivitis is reversible inflammation without attachment loss; once attachment is lost (periodontitis), the apparatus does not regrow on its own. Risk factors like smoking and diabetes meaningfully modify the host response and shape the prognosis.

The Dental Biofilm and Calculus

• Plaque is a dental biofilm: an organized, matrix-enclosed microbial community on the tooth that is more resistant to host defenses and antimicrobials than free-floating bacteria.
• Plaque begins with an acquired pellicle (a thin salivary glycoprotein layer on the tooth), to which initial colonizers (mostly Gram-positive cocci such as Streptococcus sanguinis) attach within minutes to hours.
• As plaque matures, the community shifts toward anaerobic Gram-negative species; mature subgingival plaque is the ecology that drives periodontitis.
• Calculus is mineralized plaque (calcium and phosphate from saliva supragingivally, from gingival crevicular fluid subgingivally); it is plaque-retentive but not the direct cause of disease, and supragingival calculus is usually lighter while subgingival calculus tends to be darker.

Dysbiosis and the Red Complex

• Disease is associated with a shift (dysbiosis) from a symbiotic, mostly Gram-positive aerobic community to a Gram-negative, anaerobic community capable of disrupting the host's immune balance.
• The 'red complex' (Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola) is strongly associated with chronic periodontitis.
• Porphyromonas gingivalis is regarded as a keystone pathogen: in small numbers it can subvert the host response (via gingipains and lipopolysaccharide), enabling the rest of the dysbiotic community.
• Aggregatibacter actinomycetemcomitans (with leukotoxin and other virulence factors) is associated with aggressive forms of periodontitis, especially in younger patients.

The Host Immune-Inflammatory Response

• Neutrophils (PMNs) are the first line of defense in the gingival crevice, and their dysfunction (for example in agranulocytosis, leukocyte adhesion deficiency, or Chediak-Higashi syndrome) produces severe early periodontal destruction.
• Pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha, prostaglandin E2) amplify the response and recruit more inflammatory cells.
• Matrix metalloproteinases (MMPs) released by host cells degrade collagen in the connective tissue attachment.
• RANKL (receptor activator of nuclear factor kappa B ligand) activates osteoclasts to resorb alveolar bone, while OPG (osteoprotegerin) acts as a decoy receptor; a high RANKL/OPG ratio drives bone loss.

Gingivitis to Periodontitis

• Gingivitis is inflammation of the gingiva without loss of clinical attachment or bone; bleeding on probing is the cardinal sign, and gingivitis is reversible with effective plaque control.
• Periodontitis adds loss of clinical attachment (and usually bone) to the inflammation; once lost, attachment does not regrow on its own.
• Not all gingivitis progresses to periodontitis, but periodontitis is preceded by gingivitis, and prevention is therefore the same: disrupt the biofilm and control inflammation.
• Necrotizing periodontal diseases (necrotizing gingivitis and necrotizing periodontitis) are a distinct form, classically marked by painful, ulcerated, punched-out interdental papillae, pseudomembranes, and fetor (typically in stressed or immunocompromised patients).

Risk Factors and Disease Modifiers

• Smoking is a major modifiable risk factor for periodontitis; nicotine-induced vasoconstriction can mask bleeding on probing, so smokers may have severe disease with relatively little visible bleeding, and they respond worse to therapy.
• Diabetes and periodontitis have a bidirectional relationship: poor glycemic control worsens periodontal disease, and periodontal inflammation can worsen glycemic control, making integrated management important.
• Hormonal states (puberty, pregnancy, oral contraceptive use) amplify the gingival response to plaque, producing 'pregnancy gingivitis' that is treated by plaque control rather than by removing the hormonal state.
• Drug-induced gingival enlargement is a recognized adverse effect of phenytoin (an anti-seizure drug), calcium-channel blockers such as nifedipine, and cyclosporine (an immunosuppressant); plaque control is the foundation of management.